Literature DB >> 2649286

Natural and antibody-dependent cytotoxicity in different clinical stages of human immunodeficiency virus type 1 infection.

K Ljunggren1, A Karlson, E M Fenyö, M Jondal.   

Abstract

Peripheral blood mononuclear cells, PBMC, from 64 HIV-1-infected patients were tested for natural killer (NK) and antibody-dependent cellular cytotoxicity (ADCC) functions against HIV-1-infected U937 clone 2 cells. The ADCC function was tested both with serum and effector cells from the same patient, with an HIV-1 antibody positive serum and with rabbit IgG antibodies against beta 2-microglobulin expressed on the virus-infected target cells. NK and ADCC functions were often found to be suppressed in HIV-1-infected individuals regardless of the severity of HIV-1 infection. The fact that impaired effector cell functions could be detected even in asymptomatic carriers, suggests that profound changes in cellular immunity may be present at an early stage of HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2649286      PMCID: PMC1542110     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  Antibody-dependent cellular cytotoxicity against Epstein-Barr virus-associated antigens in African patients with nasopharyngeal carcinoma.

Authors:  G R Pearson; B Johansson; G Klein
Journal:  Int J Cancer       Date:  1978-08-15       Impact factor: 7.396

2.  Prevention of oncornavirus-induced sarcomas in cats by treatment with antiviral antibodies.

Authors:  F de Noronha; R Baggs; W Schäfer; D Bolognesi
Journal:  Nature       Date:  1977-05-05       Impact factor: 49.962

3.  Immune destruction of virus-infected cells early in the infectious cycle.

Authors:  S L Shore; T L Cromeans; T J Romano
Journal:  Nature       Date:  1976-08-19       Impact factor: 49.962

4.  Epstein-Barr virus-specific antibody-dependent cellular cytotoxicity in patients with Burkitt's lymphoma.

Authors:  G R Pearson; L F Qualtiere; G Klein; T Norin; I S Bal
Journal:  Int J Cancer       Date:  1979-10-15       Impact factor: 7.396

5.  Lack of cross-reaction in antibody-dependent cellular cytotoxicity between human immunodeficiency virus (HIV) and HIV-related West African strains.

Authors:  K Ljunggren; F Chiodi; G Biberfeld; E Norrby; M Jondal; E M Fenyö
Journal:  J Immunol       Date:  1988-01-15       Impact factor: 5.422

6.  Influence of IgG and IgM receptor triggering on human natural killer cell cytotoxicity measured on the level of the single effector cell.

Authors:  J E Merrill; M Ullberg; M Jondal
Journal:  Eur J Immunol       Date:  1981-07       Impact factor: 5.532

7.  Dissociation of natural killer cell activity and antibody-dependent cell-mediated cytotoxicity in kidney allograft recipients receiving high-dose immunosuppressive therapy.

Authors:  M Lipinski; T Tursz; H Kreis; Y Finale; J L Amiel
Journal:  Transplantation       Date:  1980-03       Impact factor: 4.939

8.  Natural killer and killer cell activities in patients with primary immunodeficiencies or defects in immune interferon production.

Authors:  M Lipinski; J L Virelizier; T Tursz; C Griscelli
Journal:  Eur J Immunol       Date:  1980-04       Impact factor: 5.532

9.  Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.

Authors:  A H Rook; H Masur; H C Lane; W Frederick; T Kasahara; A M Macher; J Y Djeu; J F Manischewitz; L Jackson; A S Fauci; G V Quinnan
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

10.  Studies on the role of the host immune response in recovery from Friend virus leukemia. II. Cell-mediated immunity.

Authors:  B Chesebro; K Wehrly
Journal:  J Exp Med       Date:  1976-01-01       Impact factor: 14.307

View more
  12 in total

Review 1.  The role of infant immune responses and genetic factors in preventing HIV-1 acquisition and disease progression.

Authors:  C Farquhar; G John-Stewart
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

Review 2.  Cellular and humoral antigenic epitopes in HIV and SIV.

Authors:  D F Nixon; K Broliden; G Ogg; P A Broliden
Journal:  Immunology       Date:  1992-08       Impact factor: 7.397

3.  Independent evolution of Fc- and Fab-mediated HIV-1-specific antiviral antibody activity following acute infection.

Authors:  Anne-Sophie Dugast; Leonidas Stamatatos; Andrew Tonelli; Todd J Suscovich; Anna F Licht; Iliyana Mikell; Margaret E Ackerman; Hendrik Streeck; P J Klasse; John P Moore; Galit Alter
Journal:  Eur J Immunol       Date:  2014-08-11       Impact factor: 5.532

4.  Expression of human immunodeficiency virus genes using baculovirus expression system.

Authors:  C Y Kang
Journal:  Mol Biotechnol       Date:  1997-10       Impact factor: 2.695

5.  Deficient antibody-dependent cellular cytotoxicity against human immunodeficiency virus (HIV)-expressing target cells in perinatal HIV infection.

Authors:  U Ziegner; D Campbell; K Weinhold; I Frank; R Rutstein; S E Starr
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

6.  Altered coexpression of lectin-like receptors CD94 and CD161 on NK and T cells in HIV patients.

Authors:  Roland Jacobs; Klaus Weber; Katy Wendt; Hans Heiken; Reinhold E Schmidt
Journal:  J Clin Immunol       Date:  2004-05       Impact factor: 8.317

7.  Increased LAK activity against HIV-infected cell lines in HIV-1+ individuals.

Authors:  C Gryllis; M A Wainberg; Z Bentwich; M Gornitsky; B G Brenner
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

8.  Enhancement of natural killer cell activity in human immunodeficiency virus-infected subjects by in vitro treatment with biologic response modifier OK-432.

Authors:  X L Huang; Z Fan; T Murayama; C Rinaldo
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

9.  Contribution of nonneutralizing vaccine-elicited antibody activities to improved protective efficacy in rhesus macaques immunized with Tat/Env compared with multigenic vaccines.

Authors:  Ruth H Florese; Thorsten Demberg; Peng Xiao; LaRene Kuller; Kay Larsen; L Ebonita Summers; David Venzon; Aurelio Cafaro; Barbara Ensoli; Marjorie Robert-Guroff
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

10.  Natural killer cells in perinatally HIV-1-infected children exhibit less degranulation compared to HIV-1-exposed uninfected children and their expression of KIR2DL3, NKG2C, and NKp46 correlates with disease severity.

Authors:  Wassim M Ballan; Bien-Aimee N Vu; Brian R Long; Christopher P Loo; Jakob Michaëlsson; Jason D Barbour; Lewis L Lanier; Andrew A Wiznia; Jacobo Abadi; Glenn J Fennelly; Michael G Rosenberg; Douglas F Nixon
Journal:  J Immunol       Date:  2007-09-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.